Sakitamiwa Classification New! Access

Each stage corresponds to a distinct immunological phase: incubation, prodromal viremia, inflammatory peak, immune-mediated injury, and convalescence.

: It allows doctors to quantitatively score the quality and speed of ulcer healing, often used to test the effectiveness of medications like Proton Pump Inhibitors (PPIs) Rebamipide Procedure Monitoring

Understanding the stages of the Sakita-Miwa system is critical for evaluating drug efficacy in clinical trials, assessing bleeding risks, and tracking patient recovery over time. The Structure of the Sakita-Miwa Classification sakitamiwa classification

The Sakitamiwa classification has been applied in various contexts, including:

If you were looking for a real medical term – such as the Sakati–Nyhan classification for congenital malformations (arthrogryposis, ectodermal dysplasia) or the Kawasaki disease staging – please clarify. Otherwise, this article stands as a complete, structured guide to the hypothetical Sakitamiwa Classification system. Each stage corresponds to a distinct immunological phase:

The defect becomes much smaller. New regenerating epithelium covers most of the ulcer floor, though a small white coating may still be visible. Scarring Phase (S)

The white coating remains, but the surrounding edema begins to subside. The ulcer margin may start showing signs of regeneration. Healing Stage (H1, H2) Otherwise, this article stands as a complete, structured

Slough becomes thinner; regenerative epithelium begins to appear.

The ulcer shrinks significantly, and the white coating decreases.

The Sakita-Miwa classification is a widely recognized endoscopic system used to stage the life cycle and healing process of peptic ulcers . It divides the ulcer's progression into three main stages—Active, Healing, and Scarring—each containing two sub-stages . Key Endoscopic Characteristics Active (A) A1